MIG (CXCL9) Bovine Recombinant
MIG (CXCL9) BovineRecombinant produced in E.Coli is a non-glycosylated polypeptide chain containing 104 amino acids and having a molecular mass of approximately 18.0kDa.
MIG is purified by proprietary chromatographic techniques.
Escherichia Coli.
Sterile Filtered White lyophilized (freeze-dried) powder.
MIG Human Recombinant (CXCL9)
MIG (monokine induced by gamma-INF) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 103 amino acids and having a molecular mass of 11700 Dalton. The MIG is purified by proprietary chromatographic techniques.
MIG Human Recombinant (CXCL9), His Tag
MIG Mouse Recombinant (CXCL9)
MIG (CXCK9) Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 105 amino acids and having a molecular mass of 12208 Dalton. The MIG is purified by proprietary chromatographic techniques.
Key Biological Properties: CXCL9 is known for its cytokine activity, chemokine receptor binding, and protein binding capabilities . It is involved in various biological processes, including chemotaxis, immune response, and inflammatory response .
Expression Patterns: CXCL9 is expressed in various tissues, including the appendix, lymph nodes, nasal mucosa, and testicles . It is also found in subcutaneous adipose tissue, mesenteric lymph nodes, and the spleen .
Tissue Distribution: The expression of CXCL9 is widespread, with significant levels in the lymphoid tissues and other organs involved in immune responses .
Primary Biological Functions: CXCL9 plays a pivotal role in inducing chemotaxis, promoting the differentiation and multiplication of leukocytes, and causing tissue extravasation . It is essential for the recruitment of immune cells such as cytotoxic lymphocytes, natural killer cells, and macrophages .
Role in Immune Responses: CXCL9 is involved in the recruitment and activation of immune cells, contributing to the body’s defense against pathogens . It also plays a role in Th1 polarization, which activates immune cells in response to interferon-gamma (IFN-γ) .
Pathogen Recognition: CXCL9 is involved in the immune response to various pathogens, including bacteria and viruses .
Mechanisms with Other Molecules and Cells: CXCL9 interacts with its receptor CXCR3 to regulate immune cell migration, differentiation, and activation . This interaction is crucial for the recruitment of immune cells to sites of inflammation or infection .
Binding Partners: CXCL9 primarily binds to the CXCR3 receptor, which is expressed on various immune cells .
Downstream Signaling Cascades: The binding of CXCL9 to CXCR3 activates downstream signaling pathways, including the G protein-coupled receptor signaling pathway and the chemokine-mediated signaling pathway .
Biomedical Research: CXCL9 is extensively studied in the context of immune responses and inflammatory diseases . It is also investigated for its role in cancer and other pathological conditions .
Diagnostic Tools: CXCL9 can serve as a biomarker for various diseases, including cancers and inflammatory conditions .
Therapeutic Strategies: Targeting the CXCL9/CXCR3 axis is being explored as a potential therapeutic strategy for enhancing immune responses and treating cancers .
Development: CXCL9 plays a role in the development of the immune system by regulating the migration and differentiation of immune cells .
Aging: The expression and activity of CXCL9 can change with age, potentially affecting immune responses in older individuals .
Disease: CXCL9 is involved in various diseases, including cancers, inflammatory conditions, and infectious diseases . Its role in these diseases makes it a potential target for therapeutic interventions .